Abstract:Abstract Background Heat shock proteins (HSPs), a representative family of chaperone genes, play crucial roles in malignant progression and are pursued as attractive anti-cancer therapeutic targets. Despite tremendous efforts to develop anti-cancer drugs based on HSPs, no HSP inhibitors have thus far reached the milestone of FDA approval. There remains an unmet need to further understand the functional roles of HSPs in cancer. Methods We constructed the network for HSPs across ~ 10,000 tumor samples from The Cancer Genome Atlas (TCGA) and ~ 10,000 normal samples from Genotype-Tissue Expression (GTEx), and compared the network disruption between tumor and normal samples. We then examined the associations between HSPs and cancer hallmarks and validated these associations from multiple independent high-throughput functional screens, including Project Achilles and DRIVE. Finally, we experimentally characterized the dual function effects of HSPs in tumor proliferation and metastasis. Results We comprehensively analyzed the HSP expression landscape across multiple human cancers and revealed a global disruption of the co-expression network for HSPs. Through analyzing HSP expression alteration and its association with tumor proliferation and metastasis, we revealed dual functional effects of HSPs, in that they can simultaneously influence proliferation and metastasis in opposite directions. We experimentally characterized the dual function of two genes, DNAJC9 and HSPA14 , in lung cancer cells. We further demonstrated the generalization of this dual direction of associations between HSPs and cancer hallmarks, suggesting the necessity to more carefully evaluate HSPs as therapeutic targets and develop highly specific HSP inhibitors for cancer intervention. Conclusions Our study furnishes a holistic view of functional associations of HSPs with cancer hallmarks to aid the development of HSP inhibitors as well as other drugs in cancer therapy.

Targeting HSF1 for cancer treatment: mechanisms and inhibitor development

Heat Shock Factor 1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology

Multifaceted Roles of HSF1 in Cancer

Unveiling the HSF1 Interaction Network: Key Regulators of Its Function in Cancer

HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity

The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis

Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance

Heat Shock Proteins and HSF1 in Cancer

The small-molecule drug homoharringtonine targets HSF1 to suppress pancreatic cancer progression

Function of HSF1 and Its Research Progress in Digestive System Tumors

Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo.

Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects

Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors

Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach

Regulation of heat shock transcription factors and their roles in physiology and disease

Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies

Targeting Heat Shock Response Pathways to Treat Pancreatic Cancer

Mechanisms of Action of HSP110 and Its Cognate Family Members in Carcinogenesis

Heat Shock Factor 1 and Malignant Tumor

Targeting Hypoxia-Inducible Factor-1, for Cancer Treatment: Recent Advances in Developing Small-Molecule Inhibitors from Natural Compounds.

Upregulation of Heat Shock Factor 1 Transcription Activity is Associated with Hepatocellular Carcinoma Progression.